Orungan, Macy Kim S.

HRN: 23-05-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/24/2023
10/01/2023
IVT
70mg IVT
OD
PCAP-C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: